Anti-Human IL13 Recombinant Antibody(Tralokinumab)

Product Information

Catalog Number	YR1107
Product Name	Anti-Human IL13 Recombinant Antibody(Tralokinumab)
Molecular Name	Tralokinumab
Alias	Anti-IL13 Recombinant Antibody, Research Grade Tralokinumab
CAS Number	1044515-88-9
Target	IL13[Homo sapiens]
Isotype	IgG4 Lambda
Clonity	Monoclonal
Source	CHO Cells
Size	1mg, 5mg
Concentration	1mg/ml
Purity	>95% as determined by SDS-PAGE
Applications	ELISA, FCM, IP, FuncS, IF, Neut
Buffer	PBS, pH7.5
Background	Tralokinumab is a human monoclonal antibody which targets the cytokine interleukin 13, [1] and is designed for the treatment of asthma and other inflammatory diseases.[2] Tralokinumab was discovered by Cambridge Antibody Technology scientists, using Ribosome Display, as CAT-354[3] and taken through pre-clinical and early clinical development.
Storage	It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
Note	This product is for research use only.

Cat#	Product Name	Species	Host	Applications	Size	Price